Back to Search
Start Over
Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C
- Source :
- Canadian Journal of Gastroenterology, Vol 17, Iss 8, Pp 483-487 (2003)
- Publication Year :
- 2003
- Publisher :
- Wiley, 2003.
-
Abstract
- BACKGROUND: Treatment of chronic hepatitis C virus (HCV) infection with interferon alpha-2b and ribavirin is costly in terms of side effects, medical resources and drug costs. Furthermore, less than 50% of patients overall have a sustained virological response (SVR).
- Subjects :
- Diseases of the digestive system. Gastroenterology
RC799-869
Subjects
Details
- Language :
- English
- ISSN :
- 08357900
- Volume :
- 17
- Issue :
- 8
- Database :
- Directory of Open Access Journals
- Journal :
- Canadian Journal of Gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9d8ec1150be14a4b9e2a92e675fd0219
- Document Type :
- article
- Full Text :
- https://doi.org/10.1155/2003/351816